(19)
(11) EP 2 247 597 A1

(12)

(43) Date of publication:
10.11.2010 Bulletin 2010/45

(21) Application number: 09708143.4

(22) Date of filing: 05.02.2009
(51) International Patent Classification (IPC): 
C07D 491/04(2006.01)
A61P 29/00(2006.01)
A61K 31/436(2006.01)
A61P 3/00(2006.01)
A61P 37/00(2006.01)
C07D 491/147(2006.01)
(86) International application number:
PCT/US2009/033134
(87) International publication number:
WO 2009/100171 (13.08.2009 Gazette 2009/33)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA RS

(30) Priority: 07.02.2008 US 26816

(71) Applicant: Bristol-Myers Squibb Company
Princeton, NJ 05843-4000 (US)

(72) Inventors:
  • DUAN, Jingwu
    Princeton, New Jersey 08543 (US)
  • WEINSTEIN, David, S.
    Princeton, New Jersey 08543 (US)
  • JIANG, Bin
    Princeton, New Jersey 08543 (US)

(74) Representative: Beacham, Annabel Rose 
Dehns St Bride's House 10 Salisbury Square
London EC4Y 8JD
London EC4Y 8JD (GB)

   


(54) FUSED HETEROARYL MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-KB ACTIVITY AND USE THEREOF